APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment of Blastic-Phase CML

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Treatment of Blastic-Phase CML Industry Growth and Trends Forecast to 2032

27 December 2025103 pages

Choose your research edition.

Industry ResearchTreatment of Blastic-Phase CML Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment of Blastic-Phase CML Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Treatment of Blastic-Phase CML Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment of Blastic-Phase CML Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment of Blastic-Phase CML Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Treatment of Blastic-Phase CML market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Treatment of Blastic-Phase CML is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Treatment of Blastic-Phase CML is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treatment of Blastic-Phase CML is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Treatment of Blastic-Phase CML include Chia Tai Tianqing Pharmaceutical, CSPC Ouyi Pharmaceutical, Qilu Pharmaceutical, Lunan Pharmaceutical, Hansoh Pharmaceutical, HanHui Pharmaceuticals, Takeda Pharmaceuticals, Sanofi and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Treatment of Blastic-Phase CML market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Treatment of Blastic-Phase CML market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Treatment of Blastic-Phase CML market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Treatment of Blastic-Phase CML.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Treatment of Blastic-Phase CML market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Treatment of Blastic-Phase CML Market by Company

Chia Tai Tianqing Pharmaceutical

CSPC Ouyi Pharmaceutical

Qilu Pharmaceutical

Lunan Pharmaceutical

Hansoh Pharmaceutical

HanHui Pharmaceuticals

Takeda Pharmaceuticals

Sanofi

Pfizer

Novartis

Dr. Reddy's Laboratories

Bristol Myers Squibb

Beacon Pharmaceuticals

Apotex

Treatment of Blastic-Phase CML Segment by Type

Targeted Therapy with TKIs

Allogeneic BMT or SCT

Chemotherapy

Others

Treatment of Blastic-Phase CML Segment by Application

Hospitals

Clinics

Others

Treatment of Blastic-Phase CML Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of Blastic-Phase CML market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment of Blastic-Phase CML and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of Blastic-Phase CML.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Treatment of Blastic-Phase CML manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Treatment of Blastic-Phase CML in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Targeted Therapy with TKIs Table 2. Major Company of Allogeneic BMT or SCT Table 3. Major Company of Chemotherapy Table 4. Major Company of Others Table 5. Global Treatment of Blastic-Phase CML Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 7. Global Treatment of Blastic-Phase CML Sales Market Share in Volume by Type (2021-2026) Table 8. Global Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (US$ Million) Table 9. Global Treatment of Blastic-Phase CML Sales Market Share in Value by Type (2021-2026) Table 10. Global Treatment of Blastic-Phase CML Price by Type (2021-2026) & (US$/Unit) Table 11. Global Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 12. Global Treatment of Blastic-Phase CML Sales Market Share in Volume by Type (2027-2032) Table 13. Global Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (US$ Million) Table 14. Global Treatment of Blastic-Phase CML Sales Market Share in Value by Type (2027-2032) Table 15. Global Treatment of Blastic-Phase CML Price by Type (2027-2032) & (US$/Unit) Table 16. North America Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 17. North America Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 19. Europe Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 23. Latin America Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (US$ Million) Table 26. Treatment of Blastic-Phase CML Industry Trends Table 27. Treatment of Blastic-Phase CML Industry Drivers Table 28. Treatment of Blastic-Phase CML Industry Opportunities and Challenges Table 29. Treatment of Blastic-Phase CML Industry Restraints Table 30. Global Treatment of Blastic-Phase CML Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Treatment of Blastic-Phase CML Revenue Market Share by Company (2021-2026) Table 32. Global Treatment of Blastic-Phase CML Sales by Company (2021-2026) & (K Units) Table 33. Global Treatment of Blastic-Phase CML Sales Share by Company (2021-2026) Table 34. Global Treatment of Blastic-Phase CML Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Treatment of Blastic-Phase CML Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Treatment of Blastic-Phase CML Major Company Production Sites and Headquarters Table 37. Global Treatment of Blastic-Phase CML Company, Product Type & Application Table 38. Global Treatment of Blastic-Phase CML Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Treatment of Blastic-Phase CML by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Treatment of Blastic-Phase CML Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Treatment of Blastic-Phase CML Sales by Region (2021-2026) & (K Units) Table 43. Global Treatment of Blastic-Phase CML Sales Market Share in Volume by Region (2021-2026) Table 44. Global Treatment of Blastic-Phase CML Sales by Region (2021-2026) & (US$ Million) Table 45. Global Treatment of Blastic-Phase CML Sales Market Share in Value by Region (2021-2026) Table 46. Global Treatment of Blastic-Phase CML Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Treatment of Blastic-Phase CML Sales by Region (2027-2032) & (K Units) Table 48. Global Treatment of Blastic-Phase CML Sales Market Share in Volume by Region (2027-2032) Table 49. Global Treatment of Blastic-Phase CML Sales by Region (2027-2032) & (US$ Million) Table 50. Global Treatment of Blastic-Phase CML Sales Market Share in Value by Region (2027-2032) Table 51. Global Treatment of Blastic-Phase CML Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Treatment of Blastic-Phase CML Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 54. Global Treatment of Blastic-Phase CML Sales Market Share in Volume by Application (2021-2026) Table 55. Global Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (US$ Million) Table 56. Global Treatment of Blastic-Phase CML Sales Market Share in Value by Application (2021-2026) Table 57. Global Treatment of Blastic-Phase CML Price by Application (2021-2026) & (US$/Unit) Table 58. Global Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 59. Global Treatment of Blastic-Phase CML Sales Market Share in Volume by Application (2027-2032) Table 60. Global Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (US$ Million) Table 61. Global Treatment of Blastic-Phase CML Sales Market Share in Value by Application (2027-2032) Table 62. Global Treatment of Blastic-Phase CML Price by Application (2027-2032) & (US$/Unit) Table 63. North America Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 64. North America Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 66. Europe Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 70. Latin America Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (US$ Million) Table 73. Chia Tai Tianqing Pharmaceutical Company Information Table 74. Chia Tai Tianqing Pharmaceutical Business Overview Table 75. Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 77. Chia Tai Tianqing Pharmaceutical Recent Development Table 78. CSPC Ouyi Pharmaceutical Company Information Table 79. CSPC Ouyi Pharmaceutical Business Overview Table 80. CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 82. CSPC Ouyi Pharmaceutical Recent Development Table 83. Qilu Pharmaceutical Company Information Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Qilu Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 87. Qilu Pharmaceutical Recent Development Table 88. Lunan Pharmaceutical Company Information Table 89. Lunan Pharmaceutical Business Overview Table 90. Lunan Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Lunan Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 92. Lunan Pharmaceutical Recent Development Table 93. Hansoh Pharmaceutical Company Information Table 94. Hansoh Pharmaceutical Business Overview Table 95. Hansoh Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hansoh Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 97. Hansoh Pharmaceutical Recent Development Table 98. HanHui Pharmaceuticals Company Information Table 99. HanHui Pharmaceuticals Business Overview Table 100. HanHui Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. HanHui Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio Table 102. HanHui Pharmaceuticals Recent Development Table 103. Takeda Pharmaceuticals Company Information Table 104. Takeda Pharmaceuticals Business Overview Table 105. Takeda Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Takeda Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio Table 107. Takeda Pharmaceuticals Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sanofi Treatment of Blastic-Phase CML Product Portfolio Table 112. Sanofi Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Pfizer Treatment of Blastic-Phase CML Product Portfolio Table 117. Pfizer Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Novartis Treatment of Blastic-Phase CML Product Portfolio Table 122. Novartis Recent Development Table 123. Dr. Reddy's Laboratories Company Information Table 124. Dr. Reddy's Laboratories Business Overview Table 125. Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Product Portfolio Table 127. Dr. Reddy's Laboratories Recent Development Table 128. Bristol Myers Squibb Company Information Table 129. Bristol Myers Squibb Business Overview Table 130. Bristol Myers Squibb Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Bristol Myers Squibb Treatment of Blastic-Phase CML Product Portfolio Table 132. Bristol Myers Squibb Recent Development Table 133. Beacon Pharmaceuticals Company Information Table 134. Beacon Pharmaceuticals Business Overview Table 135. Beacon Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Beacon Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio Table 137. Beacon Pharmaceuticals Recent Development Table 138. Apotex Company Information Table 139. Apotex Business Overview Table 140. Apotex Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Apotex Treatment of Blastic-Phase CML Product Portfolio Table 142. Apotex Recent Development Table 143. North America Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. North America Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 145. North America Treatment of Blastic-Phase CML Sales Market Share by Country (2021-2026) Table 146. North America Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032) & (K Units) Table 147. North America Treatment of Blastic-Phase CML Sales Market Share Forecast by Country (2027-2032) Table 148. North America Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Treatment of Blastic-Phase CML Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Treatment of Blastic-Phase CML Market Share by Country (2021-2026) Table 151. North America Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Treatment of Blastic-Phase CML Market Share Forecast by Country (2027-2032) Table 153. Europe Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Europe Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 155. Europe Treatment of Blastic-Phase CML Sales Market Share by Country (2021-2026) Table 156. Europe Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032) & (K Units) Table 157. Europe Treatment of Blastic-Phase CML Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Treatment of Blastic-Phase CML Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Treatment of Blastic-Phase CML Market Share by Country (2021-2026) Table 161. Europe Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Treatment of Blastic-Phase CML Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 165. Asia-Pacific Treatment of Blastic-Phase CML Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032) & (K Units) Table 167. Asia-Pacific Treatment of Blastic-Phase CML Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Treatment of Blastic-Phase CML Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Treatment of Blastic-Phase CML Market Share by Country (2021-2026) Table 171. Asia-Pacific Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Treatment of Blastic-Phase CML Market Share Forecast by Country (2027-2032) Table 173. Latin America Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Latin America Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 175. Latin America Treatment of Blastic-Phase CML Sales Market Share by Country (2021-2026) Table 176. Latin America Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032) & (K Units) Table 177. Latin America Treatment of Blastic-Phase CML Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Treatment of Blastic-Phase CML Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Treatment of Blastic-Phase CML Market Share by Country (2021-2026) Table 181. Latin America Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Treatment of Blastic-Phase CML Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 185. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032) & (K Units) Table 187. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Treatment of Blastic-Phase CML Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Treatment of Blastic-Phase CML Market Share by Country (2021-2026) Table 191. Middle East and Africa Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Treatment of Blastic-Phase CML Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Treatment of Blastic-Phase CML Distributors List Table 196. Treatment of Blastic-Phase CML Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Treatment of Blastic-Phase CML Image Figure 2. Global Treatment of Blastic-Phase CML Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment of Blastic-Phase CML Market Size (2021-2032) & (US$ Million) Figure 4. Global Treatment of Blastic-Phase CML Sales (2021-2032) & (K Units) Figure 5. Targeted Therapy with TKIs Image Figure 6. Global Targeted Therapy with TKIs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Allogeneic BMT or SCT Image Figure 8. Global Allogeneic BMT or SCT Sales YoY Growth (2021-2032) & (K Units) Figure 9. Chemotherapy Image Figure 10. Global Chemotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Treatment of Blastic-Phase CML Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Treatment of Blastic-Phase CML Market Share by Type 2025 VS 2032 Figure 15. North America Treatment of Blastic-Phase CML Sales Market Share in Volume by Type in 2025 Figure 16. North America Treatment of Blastic-Phase CML Sales Market Share in Value by Type in 2025 Figure 17. Europe Treatment of Blastic-Phase CML Sales Market Share in Volume by Type in 2025 Figure 18. Europe Treatment of Blastic-Phase CML Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Treatment of Blastic-Phase CML Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Treatment of Blastic-Phase CML Sales Market Share in Value by Type in 2025 Figure 21. Latin America Treatment of Blastic-Phase CML Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Treatment of Blastic-Phase CML Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Treatment of Blastic-Phase CML Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Treatment of Blastic-Phase CML Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Treatment of Blastic-Phase CML Market Share by Application 2025 VS 2032 Figure 35. North America Treatment of Blastic-Phase CML Sales Market Share in Volume by Application in 2025 Figure 36. North America Treatment of Blastic-Phase CML Sales Market Share in Value by Application in 2025 Figure 37. Europe Treatment of Blastic-Phase CML Sales Market Share in Volume by Application in 2025 Figure 38. Europe Treatment of Blastic-Phase CML Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Treatment of Blastic-Phase CML Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Treatment of Blastic-Phase CML Sales Market Share in Value by Application in 2025 Figure 41. Latin America Treatment of Blastic-Phase CML Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Treatment of Blastic-Phase CML Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share in Value by Application in 2025 Figure 45. North America Treatment of Blastic-Phase CML Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Treatment of Blastic-Phase CML Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Treatment of Blastic-Phase CML Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Treatment of Blastic-Phase CML Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Treatment of Blastic-Phase CML Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Treatment of Blastic-Phase CML Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Treatment of Blastic-Phase CML Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Treatment of Blastic-Phase CML Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Treatment of Blastic-Phase CML Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Treatment of Blastic-Phase CML Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Treatment of Blastic-Phase CML Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Treatment of Blastic-Phase CML Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Treatment of Blastic-Phase CML Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Treatment of Blastic-Phase CML Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Treatment of Blastic-Phase CML Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Treatment of Blastic-Phase CML Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Treatment of Blastic-Phase CML Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Treatment of Blastic-Phase CML Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Treatment of Blastic-Phase CML Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Treatment of Blastic-Phase CML Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Treatment of Blastic-Phase CML Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Treatment of Blastic-Phase CML Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy with TKIs
  • Allogeneic BMT or SCT
  • Chemotherapy
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Qilu Pharmaceutical
  • Lunan Pharmaceutical
  • Hansoh Pharmaceutical
  • HanHui Pharmaceuticals
  • Takeda Pharmaceuticals
  • Sanofi
  • Pfizer
  • Novartis
  • Dr. Reddy's Laboratories
  • Bristol Myers Squibb
  • Beacon Pharmaceuticals
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Treatment of Blastic-Phase CML Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Treatment of Blastic-Phase CML Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Treatment of Blastic-Phase CML Market by Type
  6. 1.3.1 Targeted Therapy with TKIs
  7. 1.3.2 Allogeneic BMT or SCT
  8. 1.3.3 Chemotherapy
  9. 1.3.4 Others
  10. 1.4 Global Treatment of Blastic-Phase CML Market Size by Type
  11. 1.4.1 Global Treatment of Blastic-Phase CML Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Treatment of Blastic-Phase CML Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Treatment of Blastic-Phase CML Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Treatment of Blastic-Phase CML Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Treatment of Blastic-Phase CML Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Treatment of Blastic-Phase CML Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Treatment of Blastic-Phase CML Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Treatment of Blastic-Phase CML Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Treatment of Blastic-Phase CML Industry Trends
  2. 2.2 Treatment of Blastic-Phase CML Industry Drivers
  3. 2.3 Treatment of Blastic-Phase CML Industry Opportunities and Challenges
  4. 2.4 Treatment of Blastic-Phase CML Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Treatment of Blastic-Phase CML Revenue (2021-2026)
  2. 3.2 Global Top Players by Treatment of Blastic-Phase CML Sales (2021-2026)
  3. 3.3 Global Top Players by Treatment of Blastic-Phase CML Price (2021-2026)
  4. 3.4 Global Treatment of Blastic-Phase CML Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Treatment of Blastic-Phase CML Major Company Production Sites & Headquarters
  6. 3.6 Global Treatment of Blastic-Phase CML Company, Product Type & Application
  7. 3.7 Global Treatment of Blastic-Phase CML Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Treatment of Blastic-Phase CML Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Treatment of Blastic-Phase CML Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Treatment of Blastic-Phase CML Tier 1, Tier 2, and Tier 3
4 Treatment of Blastic-Phase CML Regional Status and Outlook
  1. 4.1 Global Treatment of Blastic-Phase CML Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Treatment of Blastic-Phase CML Historic Market Size by Region
  3. 4.2.1 Global Treatment of Blastic-Phase CML Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Treatment of Blastic-Phase CML Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Treatment of Blastic-Phase CML Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Treatment of Blastic-Phase CML Forecasted Market Size by Region
  7. 4.3.1 Global Treatment of Blastic-Phase CML Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Treatment of Blastic-Phase CML Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Treatment of Blastic-Phase CML Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Treatment of Blastic-Phase CML by Application
  1. 5.1 Treatment of Blastic-Phase CML Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Treatment of Blastic-Phase CML Market Size by Application
  6. 5.2.1 Global Treatment of Blastic-Phase CML Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Treatment of Blastic-Phase CML Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Treatment of Blastic-Phase CML Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Treatment of Blastic-Phase CML Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Treatment of Blastic-Phase CML Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Treatment of Blastic-Phase CML Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Treatment of Blastic-Phase CML Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Treatment of Blastic-Phase CML Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  6. 6.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 6.2 CSPC Ouyi Pharmaceutical
  8. 6.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 6.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 6.2.3 CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  12. 6.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Lunan Pharmaceutical
  20. 6.4.1 Lunan Pharmaceutical Company Information
  21. 6.4.2 Lunan Pharmaceutical Business Overview
  22. 6.4.3 Lunan Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lunan Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  24. 6.4.5 Lunan Pharmaceutical Recent Developments
  25. 6.5 Hansoh Pharmaceutical
  26. 6.5.1 Hansoh Pharmaceutical Company Information
  27. 6.5.2 Hansoh Pharmaceutical Business Overview
  28. 6.5.3 Hansoh Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hansoh Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  30. 6.5.5 Hansoh Pharmaceutical Recent Developments
  31. 6.6 HanHui Pharmaceuticals
  32. 6.6.1 HanHui Pharmaceuticals Company Information
  33. 6.6.2 HanHui Pharmaceuticals Business Overview
  34. 6.6.3 HanHui Pharmaceuticals Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HanHui Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio
  36. 6.6.5 HanHui Pharmaceuticals Recent Developments
  37. 6.7 Takeda Pharmaceuticals
  38. 6.7.1 Takeda Pharmaceuticals Company Information
  39. 6.7.2 Takeda Pharmaceuticals Business Overview
  40. 6.7.3 Takeda Pharmaceuticals Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Takeda Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio
  42. 6.7.5 Takeda Pharmaceuticals Recent Developments
  43. 6.8 Sanofi
  44. 6.8.1 Sanofi Company Information
  45. 6.8.2 Sanofi Business Overview
  46. 6.8.3 Sanofi Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Treatment of Blastic-Phase CML Product Portfolio
  48. 6.8.5 Sanofi Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Treatment of Blastic-Phase CML Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Treatment of Blastic-Phase CML Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Dr. Reddy's Laboratories
  62. 6.11.1 Dr. Reddy's Laboratories Company Information
  63. 6.11.2 Dr. Reddy's Laboratories Business Overview
  64. 6.11.3 Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Product Portfolio
  66. 6.11.5 Dr. Reddy's Laboratories Recent Developments
  67. 6.12 Bristol Myers Squibb
  68. 6.12.1 Bristol Myers Squibb Company Information
  69. 6.12.2 Bristol Myers Squibb Business Overview
  70. 6.12.3 Bristol Myers Squibb Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bristol Myers Squibb Treatment of Blastic-Phase CML Product Portfolio
  72. 6.12.5 Bristol Myers Squibb Recent Developments
  73. 6.13 Beacon Pharmaceuticals
  74. 6.13.1 Beacon Pharmaceuticals Company Information
  75. 6.13.2 Beacon Pharmaceuticals Business Overview
  76. 6.13.3 Beacon Pharmaceuticals Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Beacon Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio
  78. 6.13.5 Beacon Pharmaceuticals Recent Developments
  79. 6.14 Apotex
  80. 6.14.1 Apotex Company Information
  81. 6.14.2 Apotex Business Overview
  82. 6.14.3 Apotex Treatment of Blastic-Phase CML Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Apotex Treatment of Blastic-Phase CML Product Portfolio
  84. 6.14.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Treatment of Blastic-Phase CML Sales by Country
  2. 7.1.1 North America Treatment of Blastic-Phase CML Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Treatment of Blastic-Phase CML Sales by Country (2021-2026)
  4. 7.1.3 North America Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032)
  5. 7.2 North America Treatment of Blastic-Phase CML Market Size by Country
  6. 7.2.1 North America Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Treatment of Blastic-Phase CML Market Size by Country (2021-2026)
  8. 7.2.3 North America Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Treatment of Blastic-Phase CML Sales by Country
  2. 8.1.1 Europe Treatment of Blastic-Phase CML Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Treatment of Blastic-Phase CML Sales by Country (2021-2026)
  4. 8.1.3 Europe Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Treatment of Blastic-Phase CML Market Size by Country
  6. 8.2.1 Europe Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Treatment of Blastic-Phase CML Market Size by Country (2021-2026)
  8. 8.2.3 Europe Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Treatment of Blastic-Phase CML Sales by Country
  2. 9.1.1 Asia-Pacific Treatment of Blastic-Phase CML Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Treatment of Blastic-Phase CML Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Treatment of Blastic-Phase CML Market Size by Country
  6. 9.2.1 Asia-Pacific Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Treatment of Blastic-Phase CML Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Treatment of Blastic-Phase CML Sales by Country
  2. 10.1.1 South America Treatment of Blastic-Phase CML Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Treatment of Blastic-Phase CML Sales by Country (2021-2026)
  4. 10.1.3 South America Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032)
  5. 10.2 South America Treatment of Blastic-Phase CML Market Size by Country
  6. 10.2.1 South America Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Treatment of Blastic-Phase CML Market Size by Country (2021-2026)
  8. 10.2.3 South America Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Treatment of Blastic-Phase CML Sales by Country
  2. 11.1.1 Middle East and Africa Treatment of Blastic-Phase CML Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Treatment of Blastic-Phase CML Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Treatment of Blastic-Phase CML Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Treatment of Blastic-Phase CML Market Size by Country
  6. 11.2.1 Middle East and Africa Treatment of Blastic-Phase CML Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Treatment of Blastic-Phase CML Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Treatment of Blastic-Phase CML Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Treatment of Blastic-Phase CML Value Chain Analysis
  2. 12.1.1 Treatment of Blastic-Phase CML Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Treatment of Blastic-Phase CML Production Mode & Process
  7. 12.2 Treatment of Blastic-Phase CML Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Treatment of Blastic-Phase CML Distributors
  10. 12.2.3 Treatment of Blastic-Phase CML Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst